Available online 18 November 2023

This work was conceptualized by Drs. Chan and Aryasomayajula. The data was obtained from the USCS Database and National Center for Health Statistics by Dr. Liao and analyzed by Dr. Aryasomayajula. Drs. Aryasomayajula, Stewart, and Chan contributed to the primary writing of the manuscript. Drs. Eakin, Reiser, Chow, Kapp and Chan contributed to editing of final manuscript. This work was presented as an oral presentation at the 54th Annual Society of Gynecologic Oncology Meeting; March 25–28,

We would like to acknowledge The Fisher Foundation and Denise Cobb Hale for their generous administrative support. JK Chan reports personal fees from Acerta, Aravive, AstraZeneca, Biodesix, Clovis, Eisai, Janssen/J&J, Oxigene/Mateon, Roche/Genentech and GlaxoSmithKline/Tesaro. All other authors report no conflict of interest. No sources of financial support were used for this study.

There are more references available in the full text version of this article.

© 2023 Elsevier Inc. All rights reserved.